These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 20142528

  • 1. Autoantibody-mediated dysfunction of sympathetic neurons in guillain-barre syndrome.
    Lehmann HC, Jangouk P, Kierysch EK, Meyer zu Hörste G, Hartung HP, Kieseier BC.
    Arch Neurol; 2010 Feb; 67(2):203-10. PubMed ID: 20142528
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M, Suzuki S, Takada K, Kusunoki S.
    J Neuroimmunol; 2011 Oct 28; 239(1-2):87-90. PubMed ID: 21914557
    [Abstract] [Full Text] [Related]

  • 3. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Zhang HL, Zhang XM, Mao XJ, Deng H, Li HF, Press R, Fredrikson S, Zhu J.
    Acta Neurol Scand; 2012 Feb 28; 125(2):129-35. PubMed ID: 21434877
    [Abstract] [Full Text] [Related]

  • 4. Nodal proteins are target antigens in Guillain-Barré syndrome.
    Devaux JJ, Odaka M, Yuki N.
    J Peripher Nerv Syst; 2012 Mar 28; 17(1):62-71. PubMed ID: 22462667
    [Abstract] [Full Text] [Related]

  • 5. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.
    Ann Biol Clin (Paris); 2002 Mar 28; 60(5):589-97. PubMed ID: 12368145
    [Abstract] [Full Text] [Related]

  • 6. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen D, Giannopoulos K, Gray I, Gregson N, Makowska A, Pritchard J, Hughes RA.
    J Peripher Nerv Syst; 2005 Jun 28; 10(2):174-80. PubMed ID: 15958128
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R, Nennesmo I, Kouwenhoven M, Huang YM, Link H, Pashenkov M.
    J Neuroimmunol; 2005 Feb 28; 159(1-2):165-76. PubMed ID: 15652416
    [Abstract] [Full Text] [Related]

  • 8. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
    Taguchi K, Ren J, Utsunomiya I, Aoyagi H, Fujita N, Ariga T, Miyatake T, Yoshino H.
    J Neurol Sci; 2004 Oct 15; 225(1-2):91-8. PubMed ID: 15465091
    [Abstract] [Full Text] [Related]

  • 9. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
    Buchwald B, Ahangari R, Weishaupt A, Toyka KV.
    Ann Neurol; 2002 Jun 15; 51(6):673-80. PubMed ID: 12112071
    [Abstract] [Full Text] [Related]

  • 10. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M, Yuki N, Tatsumoto M, Tateno M, Hirata K.
    J Neurol; 2004 Jan 15; 251(1):24-9. PubMed ID: 14999485
    [Abstract] [Full Text] [Related]

  • 11. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K, Sonoo M, Ogawa G, Kamakura K, Ueda-Sada M, Arita M, Motoyoshi K, Kusunoki S.
    Neurology; 2008 Nov 18; 71(21):1683-90. PubMed ID: 19015484
    [Abstract] [Full Text] [Related]

  • 12. [Antiganglioside antibodies: when, which and for what].
    Gallardo E, Rojas-García R, Belvís R, Serrano-Munuera C, Ortiz E, Ortiz N, Grau J, Illa I.
    Neurologia; 2001 Nov 18; 16(7):293-7. PubMed ID: 11485721
    [Abstract] [Full Text] [Related]

  • 13. Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome.
    Csurhes PA, Sullivan AA, Green K, Greer JM, Pender MP, McCombe PA.
    J Clin Neurosci; 2005 May 18; 12(4):409-15. PubMed ID: 15925771
    [Abstract] [Full Text] [Related]

  • 14. Ca channel currents inhibited by serum from select patients with Guillain-Barré syndrome.
    Nakatani Y, Kawakami K, Nagaoka T, Utsunomiya I, Tanaka K, Yoshino H, Miyatake T, Hoshi K, Taguchi K.
    Eur Neurol; 2007 May 18; 57(1):11-8. PubMed ID: 17108689
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L, Altuntas F, Aydogdu I, Turgut B, Kocyigit I, Hacioglu SK, Ismailogullari S, Turgut N, Erkurt MA, Sari I, Oztekin M, Solmaz M, Eser B, Ersoy AO, Unal A, Cetin M.
    Transfus Apher Sci; 2008 Apr 18; 38(2):109-15. PubMed ID: 18331814
    [Abstract] [Full Text] [Related]

  • 16. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R, Pashenkov M, Jin JP, Link H.
    J Clin Immunol; 2003 Jul 18; 23(4):259-67. PubMed ID: 12959218
    [Abstract] [Full Text] [Related]

  • 17. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
    Odaka M, Yuki N, Hirata K.
    J Neurol; 2003 Aug 18; 250(8):913-6. PubMed ID: 12928908
    [Abstract] [Full Text] [Related]

  • 18. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
    Buchwald B, Toyka KV, Zielasek J, Weishaupt A, Schweiger S, Dudel J.
    Ann Neurol; 1998 Dec 18; 44(6):913-22. PubMed ID: 9851436
    [Abstract] [Full Text] [Related]

  • 19. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
    Fokkink WJ, Selman MH, Dortland JR, Durmuş B, Kuitwaard K, Huizinga R, van Rijs W, Tio-Gillen AP, van Doorn PA, Deelder AM, Wuhrer M, Jacobs BC.
    J Proteome Res; 2014 Mar 07; 13(3):1722-30. PubMed ID: 24533874
    [Abstract] [Full Text] [Related]

  • 20. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA, Chen ZW, Cook SD, Mithen FA, Singhal BS.
    Res Commun Mol Pathol Pharmacol; 2001 Jul 07; 109(1-2):115-23. PubMed ID: 11458979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.